Cargando…
Commentary on the ECTRIMS–EAN guideline for pharmacological treatment of multiple sclerosis
Autor principal: | Thompson, Alan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912310/ https://www.ncbi.nlm.nih.gov/pubmed/29707041 http://dx.doi.org/10.1177/1756286418770378 |
Ejemplares similares
-
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
por: Otero-Romero, Susana, et al.
Publicado: (2023) -
Empfehlungen zur COVID-19-Impfung bei MS -Positionspapier von ECTRIMS und EAN
por: Müller, Thomas
Publicado: (2021) -
EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis
por: Solari, Alessandra, et al.
Publicado: (2020) -
New evidence for the pharmacological intervention promoting neurorecovery after stroke: results from the joint EAN-EFNR guidelines
por: Muresanu, Dafin, et al.
Publicado: (2021) -
Does attendance at the ECTRIMS congress impact on therapeutic
decisions in multiple sclerosis care?
por: Saposnik, Gustavo, et al.
Publicado: (2019)